Oncovet Clinical Research


Contract research organization focused on veterinary clinical research and comparative (One Health) studies. Provides end-to-end services for preclinical and clinical development in companion animals (dogs, cats) including clinical trial design and conduct, regulatory and ethics support, laboratory histology and immunohistochemistry, a biobank of annotated animal samples, clinical data management and biostatistics, and specialized R&D platforms (medical imaging, irradiation). Operates a network of veterinary clinics across multiple European countries and, following integration into larger clinical research groups in 2024, is aligned with group-level compliance, quality, IT and multi-country delivery standards to support expanded geographic coverage.

Industries

biotechnology
medical
pharmaceutical
therapeutics
veterinary

Nr. of Employees

small (1-50)

Oncovet Clinical Research


Services

Tailored design and operational coordination of veterinary clinical trials from proof-of-concept to pivotal studies, including site management and monitoring.

Support for ethical review, regulatory submissions, GCP/VICH-aligned compliance and quality system implementation for clinical programs.

Custom histopathology analyses including fixation-to-staining workflows, special stains, scoring development, blinded reads and illustrated pathology reports.

Design and validation of IHC protocols for new markers, antibody selection, automated staining workflows with controls and detailed reporting.

Provision of annotated biological sample collections (serum, plasma, tissues, DNA/RNA, cells) with quality assurance and associated clinical metadata for research use.

Clinical data capture, database management and statistical analysis services to support study interpretation and reporting.

Expertise Areas

  • Veterinary clinical trial management
  • Comparative medicine and translational oncology
  • Histology and immunohistochemistry workflows
  • Biobanking and annotated sample management
  • Show More (5)

Key Technologies

  • Immunohistochemistry
  • Histopathology (H&E and special stains)
  • Automated immunostaining platforms
  • Nucleic acid extraction (DNA/RNA)
  • Show More (4)

News & Updates

As of 1 October 2024, the organisation transitioned to be part of Clinaxel, aligning to group standards for compliance, quality, IT and project delivery to support broader geographic coverage.

Announcement of acquisition by an international clinical research group, expanding presence in Europe (teams in France, Italy and Poland) and broadening capabilities for field clinical studies in animal health, pet food and translational/device studies for human pharma/biotech.

Participation in a clinical study addressing chronic kidney disease in dogs.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.